Compare Gilead Sciences, Inc. (GILD) vs Solaredge Technologies Inc (SEDG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs Solaredge Technologies Inc — how do they compare? Gilead Sciences, Inc. trades at $136.45 (market cap $163.51B), while Solaredge Technologies Inc trades at $54.62 (market cap $3.32B). The key difference: Gilead Sciences, Inc. is far larger — about 49.3× Solaredge Technologies Inc's market cap, and Gilead Sciences, Inc. pays a 2.49% dividend while Solaredge Technologies Inc pays none. Which is the better fit depends on your goals.
| GILD | SEDG | |
|---|---|---|
Market Cap | $163.51B | $3.32B |
Sector | Health | Technology |
52-Week High | $155.80 | $78.51 |
52-Week Low | $108.22 | $24.42 |
Enterprise Value | $178.05B | $3.25B |
Dividend Yield | 2.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $133.30, up 2.51% today, with strong technical momentum above key support at $130. The company demonstrates robust fundamentals with a 30.99% net income margin and consistent earnings beats in recent quarters. Recent FDA and EC approvals for Trodelvy in metastatic triple-negative breast cancer highlight growth potential beyond its HIV franchise.
Outlook remains positive with a consensus price target of $152.83 offering 14.6% upside, though risks include patent expirations and competitive pressures. The stock presents a compelling opportunity driven by oncology expansion and strong cash flow generation, supported by overwhelming analyst bullish sentiment.
SolarEdge Technologies (SEDG) trades at $52.00, down 6.34% in the past 24 hours, with technical indicators showing a neutral signal. The company reported a net loss of $405.45 million in 2025 despite revenue of $1.18 billion, with negative profit margins and ROE. Recent earnings show mixed results, beating estimates in Q3 and Q4 2025 but missing in Q1 2026. Analyst sentiment is divided, with a consensus price target of $35.65, below the current price. Cash flow improved in 2025, but high debt levels and competitive pressures remain concerns.
The outlook for SEDG is cautious due to persistent losses and weak profitability, though recent cash flow improvement offers some stability. Investment opportunities hinge on solar demand recovery and execution on cost controls. Key risks include intense competition, regulatory uncertainty, and reliance on solar market cycles. Investors should monitor upcoming Q2 2026 earnings for signs of turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →
